Novavax Inc
Biotechnology
Healthcare
NVAX
177 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
8.90
52 week high
14.68
high
9.04
52 week low
0.00
previous Close
8.87
P/E ratio
market cap
1.42 B
div yield
0
net incoming
107 M
-79.46 %
net profit margin
44.52 %
-33.00 %
operating incoming
106 M
-79.50 %
net change in cash
-9.50 M
96.44 %
cash on hand
264 M
0.44 %
cost of revenue
14.23 M
0.78 %
top